Ran Meng

3.7k total citations
154 papers, 2.5k citations indexed

About

Ran Meng is a scholar working on Neurology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ran Meng has authored 154 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Neurology, 52 papers in Epidemiology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ran Meng's work include Acute Ischemic Stroke Management (45 papers), Cerebral Venous Sinus Thrombosis (43 papers) and Cerebrovascular and Carotid Artery Diseases (20 papers). Ran Meng is often cited by papers focused on Acute Ischemic Stroke Management (45 papers), Cerebral Venous Sinus Thrombosis (43 papers) and Cerebrovascular and Carotid Artery Diseases (20 papers). Ran Meng collaborates with scholars based in China, United States and United Kingdom. Ran Meng's co-authors include Xunming Ji, Yuchuan Ding, Da Zhou, Jiayue Ding, Jianping Jia, Dalong Zhu, Wenbo Zhao, Sijie Li, Jingyuan Ya and Yan Bi and has published in prestigious journals such as Advanced Materials, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Ran Meng

141 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Meng China 26 785 662 553 378 365 154 2.5k
Chuanjie Wu China 28 940 1.2× 788 1.2× 407 0.7× 70 0.2× 286 0.8× 129 2.2k
Tsong‐Hai Lee Taiwan 28 638 0.8× 811 1.2× 111 0.2× 155 0.4× 382 1.0× 182 3.0k
Zhen‐Ni Guo China 31 989 1.3× 1.0k 1.6× 197 0.4× 104 0.3× 803 2.2× 172 3.8k
Wusheng Zhu China 33 717 0.9× 1.1k 1.6× 76 0.1× 172 0.5× 581 1.6× 132 3.0k
Meng Wei China 28 383 0.5× 456 0.7× 416 0.8× 196 0.5× 348 1.0× 154 3.3k
José Vivancos Spain 31 735 0.9× 1.3k 2.0× 158 0.3× 85 0.2× 852 2.3× 127 3.7k
John R. Vender United States 29 1.0k 1.3× 404 0.6× 270 0.5× 124 0.3× 367 1.0× 89 2.5k
Sen Lin China 31 1.2k 1.5× 936 1.4× 129 0.2× 74 0.2× 750 2.1× 145 3.3k
Kazuo Yamashiro Japan 23 512 0.7× 359 0.5× 93 0.2× 112 0.3× 490 1.3× 95 2.0k
Chung‐Ching Chio Taiwan 37 1.0k 1.3× 583 0.9× 259 0.5× 207 0.5× 444 1.2× 129 3.7k

Countries citing papers authored by Ran Meng

Since Specialization
Citations

This map shows the geographic impact of Ran Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Meng more than expected).

Fields of papers citing papers by Ran Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Meng. The network helps show where Ran Meng may publish in the future.

Co-authorship network of co-authors of Ran Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Meng. A scholar is included among the top collaborators of Ran Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Meng. Ran Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fang, et al.. (2025). Propofol reduces breast cancer cell stemness via FOXO3/SOX2 axis. Journal of Cancer. 16(5). 1555–1562.
2.
Xu, Jian, et al.. (2025). Bidirectional impact of dementia and aspiration pneumonia on cognitive decline in older adults: A retrospective cohort analysis. Geriatrics and gerontology international. 25(11). 1481–1487.
4.
Zhang, Xiaoming, Kun Fang, Xiangqian Huang, et al.. (2025). Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles in ischemic stroke: A meta-analysis of preclinical studies. Brain Research Bulletin. 221. 111219–111219. 5 indexed citations
5.
Meng, Ran, Dong Chao, Xingxiang Chen, et al.. (2025). Tetraspanin OsTET8 acts as a negative regulator of root development in rice. Rice. 18(1). 104–104.
8.
Qian, Kang, Peng Yang, Yixian Li, et al.. (2024). Rational fusion design inspired by cell-penetrating peptide: SS31/S-14 G Humanin hybrid peptide with amplified multimodal efficacy and bio-permeability for the treatment of Alzheimer's disease. Asian Journal of Pharmaceutical Sciences. 19(4). 100938–100938. 4 indexed citations
9.
Meghea, Cristian, et al.. (2024). Community Health Workers: Improving Home Visiting Engagement of High-Risk Birthing People in Segregated Neighborhoods. Journal of Public Health Management and Practice. 30(3). E124–E134. 3 indexed citations
10.
Roman, Lee Anne, et al.. (2024). Neighborhood Racialized Economic Polarization, Home Visiting Coverage, and Adverse Birth Outcomes in a Medicaid-eligible Population. Women s Health Issues. 34(4). 340–349. 2 indexed citations
11.
Wu, Yan, Chuanjie Wu, Ran Meng, et al.. (2024). Efficacy and Safety of a Dedicated Device for Cerebral Venous Thrombectomy: A Pilot Randomized Clinical Trial. Stroke. 56(1). 5–13. 3 indexed citations
12.
Lan, Duo, Siying Song, Xiaoming Zhang, et al.. (2024). Effects of batroxobin on the antithrombotic system in patients with cerebral venous thrombosis: Clues to mechanisms. CNS Neuroscience & Therapeutics. 30(8). e14861–e14861. 1 indexed citations
13.
Liu, Jie, et al.. (2023). Amelioration of diabetic kidney injury with dapagliflozin is associated with suppressing renal HMGB1 expression and restoring autophagy in obese mice. Journal of Diabetes and its Complications. 37(3). 108409–108409. 11 indexed citations
14.
Qian, Kang, Xiaoyan Bao, Yixian Li, et al.. (2022). Cholinergic Neuron Targeting Nanosystem Delivering Hybrid Peptide for Combinatorial Mitochondrial Therapy in Alzheimer’s Disease. ACS Nano. 16(7). 11455–11472. 67 indexed citations
15.
Wu, Xiaoqin, Yuchuan Ding, Xunming Ji, & Ran Meng. (2022). Jugular foramen and venous collaterals may help to discriminate congenital from post-thrombotic jugular stenosis. European journal of medical research. 27(1). 10–10.
16.
Rosis, Alessandro De, et al.. (2021). Double-D2Q9 lattice Boltzmann models with extended equilibrium for two-dimensional magnetohydrodynamic flows. Physics of Fluids. 33(3). 7 indexed citations
17.
Li, Min, et al.. (2019). Internal jugular vein stenosis induced by tortuous internal carotid artery compression: two case reports and literature review. Journal of International Medical Research. 47(8). 3926–3933. 9 indexed citations
18.
Zhou, Da, Ran Meng, Sijie Li, et al.. (2017). Advances in chronic cerebral circulation insufficiency. CNS Neuroscience & Therapeutics. 24(1). 5–17. 49 indexed citations
19.
Feng, Bin, Ran Meng, Bin Huang, et al.. (2016). Silymarin alleviates hepatic oxidative stress and protects against metabolic disorders in high-fat diet-fed mice. Free Radical Research. 50(3). 314–327. 50 indexed citations
20.
Li, Wenlong, Eric Li, Ran Meng, Tao Wang, & Carole Dulong. (2006). Performance analysis of Java concurrent programming: a case study of video mining system. International Parallel and Distributed Processing Symposium. 232–232. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026